Inhibiting and Remodeling Toxic Amyloid-Beta Oligomer Formation Using a Computationally Designed Drug Molecule That Targets Alzheimer’s Disease

Written By Jamison Wright

https://pubs.acs.org/doi/10.1007/s13361-018-1975-1

Jamison Wright https://jamisonwright.com
Previous

Modulating ALS-Related Amyloidogenic TDP-43307–319 Oligomeric Aggregates with Computationally Derived Therapeutic Molecules
Next

Novel Method for Pharmacophore Analysis by Examining the Joint Pharmacophore Space